BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17446896)

  • 1. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature.
    Wang Y; Liu X; Hnatowich DJ
    Nat Protoc; 2007; 2(4):972-8. PubMed ID: 17446896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules.
    Wang Y; Liu G; Hnatowich DJ
    Nat Protoc; 2006; 1(3):1477-80. PubMed ID: 17406438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
    Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.
    Chang F; Qu T; Rusckowski M; Hnatowich DJ
    Appl Radiat Isot; 1999 Apr; 50(4):723-32. PubMed ID: 10101833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
    Li Y; Tan T; Zheng J; Zhang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
    Winnard P; Chang F; Rusckowski M; Mardirossian G; Hnatowich DJ
    Nucl Med Biol; 1997 Jul; 24(5):425-32. PubMed ID: 9290078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.
    Hnatowich DJ; Qu T; Chang F; Ley AC; Ladner RC; Rusckowski M
    J Nucl Med; 1998 Jan; 39(1):56-64. PubMed ID: 9443739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized preparation of a (99m)Tc-radiolabeled probe for tracing microRNA.
    Kang L; Xu XJ; Ma C; Wang RF; Yan P; Zhang CL; Sun HW; Li D
    Cell Biochem Biophys; 2015 Mar; 71(2):905-12. PubMed ID: 25315639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the stability of technetium-labeled peptides to challenge with cysteine.
    Stalteri MA; Bansal S; Hider R; Mather SJ
    Bioconjug Chem; 1999; 10(1):130-6. PubMed ID: 9893974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the labeling of S-acetyl NHS-MAG(3)-conjugated morpholino oligomers.
    Liu G; Zhang S; He J; Zhu Z; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2002; 13(4):893-7. PubMed ID: 12121147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
    Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
    J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.
    Teodoro R; Faintuch BL; Núñez EG; Queiróz RG
    Nucl Med Biol; 2011 Jan; 38(1):113-20. PubMed ID: 21220134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of carrier on 99mTc radiopharmaceuticals.
    Ballinger JR
    Q J Nucl Med; 2002 Sep; 46(3):224-32. PubMed ID: 12134138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasible approach to evaluate the relative reactivity of NHS-ester activated group with primary amine-derivatized DNA analogue and non-derivatized impurity.
    Dou S; Virostko J; Greiner DL; Powers AC; Liu G
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(2):69-78. PubMed ID: 25621701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An N2S2 bifunctional chelator for technetium-99m and rhenium: complexation, conjugation, and epimerization to a single isomer.
    Luyt LG; Jenkins HA; Hunter DH
    Bioconjug Chem; 1999; 10(3):470-9. PubMed ID: 10346880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of temperature and alkaline pH on the labeling of free and conjugated MAG3 with technetium-99m.
    Hnatowich DJ; Chang F; Lei K; Qu T; Rusckowski M
    Appl Radiat Isot; 1997 May; 48(5):587-94. PubMed ID: 9204521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.
    Banerjee SR; Maresca KP; Francesconi L; Valliant J; Babich JW; Zubieta J
    Nucl Med Biol; 2005 Jan; 32(1):1-20. PubMed ID: 15691657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology.
    Dunn-Dufault R; Pollak A; Thornback JR; Ballinger JR
    Bioconjug Chem; 1999; 10(5):832-7. PubMed ID: 10502350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).
    Kasina S; Sanderson JA; Fitzner JN; Srinivasan A; Rao TN; Hobson LJ; Reno JM; Axworthy DB; Beaumier PL; Fritzberg AR
    Bioconjug Chem; 1998; 9(1):108-17. PubMed ID: 9460553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.